Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Insulin receptor substrate signaling suppresses neonatal autophagy in the heart
Christian Riehle, … , Morris F. White, E. Dale Abel
Christian Riehle, … , Morris F. White, E. Dale Abel
Published November 1, 2013
Citation Information: J Clin Invest. 2013;123(12):5319-5333. https://doi.org/10.1172/JCI71171.
View: Text | PDF
Research Article Cardiology

Insulin receptor substrate signaling suppresses neonatal autophagy in the heart

  • Text
  • PDF
Abstract

The induction of autophagy in the mammalian heart during the perinatal period is an essential adaptation required to survive early neonatal starvation; however, the mechanisms that mediate autophagy suppression once feeding is established are not known. Insulin signaling in the heart is transduced via insulin and IGF-1 receptors (IGF-1Rs). We disrupted insulin and IGF-1R signaling by generating mice with combined cardiomyocyte-specific deletion of Irs1 and Irs2. Here we show that loss of IRS signaling prevented the physiological suppression of autophagy that normally parallels the postnatal increase in circulating insulin. This resulted in unrestrained autophagy in cardiomyocytes, which contributed to myocyte loss, heart failure, and premature death. This process was ameliorated either by activation of mTOR with aa supplementation or by genetic suppression of autophagic activation. Loss of IRS1 and IRS2 signaling also increased apoptosis and precipitated mitochondrial dysfunction, which were not reduced when autophagic flux was normalized. Together, these data indicate that in addition to prosurvival signaling, insulin action in early life mediates the physiological postnatal suppression of autophagy, thereby linking nutrient sensing to postnatal cardiac development.

Authors

Christian Riehle, Adam R. Wende, Sandra Sena, Karla Maria Pires, Renata Oliveira Pereira, Yi Zhu, Heiko Bugger, Deborah Frank, Jack Bevins, Dong Chen, Cynthia N. Perry, Xiaocheng C. Dong, Steven Valdez, Monika Rech, Xiaoming Sheng, Bart C. Weimer, Roberta A. Gottlieb, Morris F. White, E. Dale Abel

×

Figure 5

Decreased autophagy and attenuated heart failure by aa treatment in CIRS12KO mice.

Options: View larger image (or click on image) Download as PowerPoint
Decreased autophagy and attenuated heart failure by aa treatment in CIRS...
(A) Representative H&E stains from WT and CIRS12KO hearts (6 weeks of age) after saline or aa treatment. Scale bar: 3 mm. (B) Survival curves showing that aa supplementation increased the average lifespan of CIRS12KO mice from 6.6 to 11.1 weeks (P = 0.0001, log-rank test). (C) Autophagy flux after chloroquine (CQ) injection (2 weeks of age), as measured by LC3 immunoblotting. (D) Heart weight/tibia length (HW/TL) and (E) wet lung weight/tibia length (WLW/TL) ratios after saline or aa treatment in 6-week-old mice. (F and G) Representative H&E and trichrome staining (F) and stereological analysis (G; n = 6–7). Scale bar: 20 μm. (H) Time course for LVDs and FS (n = 6–9). (I) Invasive measurement of LV pressures in WT and CIRS12KO hearts after saline or aa treatment at 6 weeks of age, as assessed by catheterization. LV Dev P, LV developed pressure; LVMP, LV minimum pressure; Max dP/dt and Min dP/dt, maximal rates of increase and decrease, respectively, in LV pressure. *P < 0.05 vs. WT same treatment, †P < 0.05 vs. saline same genotype, ‡P < 0.05 vs. same genotype no chloroquine, ANOVA with Fisher’s PLSD.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts